Biodegradable vesicular nanocarriers based on poly(ε-caprolactone)-block-poly(ethyl ethylene phosphate) for drug delivery

被引:51
作者
Wang, Feng [1 ,2 ]
Wang, Yu-Cai [3 ]
Yan, Li-Feng [4 ]
Wang, Jun [1 ,2 ]
机构
[1] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China
[2] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China
[3] Univ Sci & Technol China, Dept Polymer Sci & Engn, Hefei 230026, Anhui, Peoples R China
[4] Univ Sci & Technol China, Dept Chem Phys, Hefei 230026, Anhui, Peoples R China
基金
中国国家自然科学基金;
关键词
Polyphosphoester; Polymer vesicle; Drug delivery; POLYMERSOME ENCAPSULATED HEMOGLOBIN; ALUMINUM ISOPROPOXIDE; POLYPEPTIDE VESICLES; EPSILON-CAPROLACTONE; COPOLYMER VESICLES; CONTROLLED-RELEASE; DIBLOCK COPOLYMER; OXYGEN CARRIER; LIPOSOMES; POLYMERIZATIONS;
D O I
10.1016/j.polymer.2009.09.007
中图分类号
O63 [高分子化学(高聚物)];
学科分类号
070305 ; 080501 ; 081704 ;
摘要
Biodegradable polymer vesicle for drug delivery is reported. Poly(epsilon-caprolactone)-block-poly(ethyl ethylene phosphate) with well-defined structure (PCL150-b-PEEP30) has been prepared by ring-opening polymerization. It forms vesicles in aqueous solution using the thin-film hydration method and further exclusion of the as-formed vesicles results in vesicles at nano-size, demonstrated by confocal laser scanning microscope (CLSM) and transmission electron microscopy observations. Doxorubicin (DOX) has been loaded into the vesicles with a loading content of 4.38% using an acid gradient method. The release of DOX from the vesicles is accelerated in the presence of an enzyme phosphodiesterase I that is known to catalyze the degradation of polyphosphoester, achieving 83.8% release of total loaded DOX in 140 h. The DOX-loaded vesicles can be successfully internalized by A549 cells, and it results in enhanced inhibition to A549 cell proliferation, likely owning to the sustained intracellular release of DOX as observed by CLSM. With these properties, the vesicles based on the block copolymer of PCL and PEEP are attractive as drug carriers for pharmaceutical application. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5048 / 5054
页数:7
相关论文
共 41 条
[21]   Cyclic nucleotide phosphodiesterase (PDE) superfamily: A new target for the development of specific therapeutic agents [J].
Lugnier, C .
PHARMACOLOGY & THERAPEUTICS, 2006, 109 (03) :366-398
[22]  
MAEDA H, 1989, CRIT REV THER DRUG, V6, P193
[23]   UPTAKE OF ADRIAMYCIN INTO LARGE UNILAMELLAR VESICLES IN RESPONSE TO A PH GRADIENT [J].
MAYER, LD ;
BALLY, MB ;
CULLIS, PR .
BIOCHIMICA ET BIOPHYSICA ACTA, 1986, 857 (01) :123-126
[24]   Stimuli-Responsive Polymersomes for Programmed Drug Delivery [J].
Meng, Fenghua ;
Zhong, Zhiyuan ;
Feijen, Jan .
BIOMACROMOLECULES, 2009, 10 (02) :197-209
[25]   Biodegradable polymersomes as a basis for artificial cells: encapsulation, release and targeting [J].
Meng, FH ;
Engbers, GHM ;
Feijen, J .
JOURNAL OF CONTROLLED RELEASE, 2005, 101 (1-3) :187-198
[26]   Glucose-oxidase based self-destructing polymeric vesicles [J].
Napoli, A ;
Boerakker, MJ ;
Tirelli, N ;
Nolte, RJM ;
Sommerdijk, NAJM ;
Hubbell, JA .
LANGMUIR, 2004, 20 (09) :3487-3491
[27]   PREPARATION OF LIPOSOMES OF DEFINED SIZE DISTRIBUTION BY EXTRUSION THROUGH POLYCARBONATE MEMBRANES [J].
OLSON, F ;
HUNT, CA ;
SZOKA, FC ;
VAIL, WJ ;
PAPAHADJOPOULOS, D .
BIOCHIMICA ET BIOPHYSICA ACTA, 1979, 557 (01) :9-23
[28]  
Park JW, 2002, CLIN CANCER RES, V8, P1172
[29]   Polymer vesicles in vivo: correlations with PEG molecular weight [J].
Photos, PJ ;
Bacakova, L ;
Discher, B ;
Bates, FS ;
Discher, DE .
JOURNAL OF CONTROLLED RELEASE, 2003, 90 (03) :323-334
[30]   Temperature-controlled assembly and release from polymer vesicles of poly(ethylene oxide)-block-poly(N-isopropylacrylamide) [J].
Qin, Shuhui ;
Geng, Yan ;
Discher, Dennis E. ;
Yang, Shu .
ADVANCED MATERIALS, 2006, 18 (21) :2905-+